Cencora INC CENCORA INC ORD SHS
Cencora INC CENCORA INC ORD SHS/ US03073E1055 /
0HF3
|
19/11/2024 17:26:40
|
Diferencia
+0.24
|
Volumen |
Bid- |
Ask- |
Capitalización de mecado |
Dividendo A. |
P/E Ratio |
|
243.45USD
|
+0.10%
|
432
Volumen de negocios: 104,677.43 |
-Volumen de oferta: - |
-Tamaño/ Volumen/ Formato de Ask: - |
47.92 mil millonesUSD |
0.80% |
28.21 |
Descripción de negocio
Cencora, formerly known as AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, Cencora delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
Consejo de gestión & Consejo de supervisión
| CEO |
| Steven H. Collis |
| Consejo de gestión |
| James F. Cleary, Jr., Elizabeth S. Campbell, Gina K. Clark, Kourosh Q. Pirouz, Lazarus Krikorian, Leslie E. Donato, Robert P. Mauch, Silvana Battaglia, Jennifer Dubas |
| Consejo de supervisión |
| Steven H. Collis, D. Mark Durcan, Dennis M. Nally, Henry W. McGee, Kathleen W. Hyle, Lon R. Greenberg, Ornella Barra, Richard W. Gochnauer, Redonda Miller, Lorence H. Kim, M.D. |
Datos de la empresa
| Nombre: |
Cencora Inc |
| Dirección: |
1 West First Avenue,Conshohocken, PA 19428-1800, USA |
| Teléfono: |
+1-610-727-7000 |
| Fax: |
+1-800-640-5221 |
| E-mail: |
InvestorRelations@cencora.com
|
| Internet: |
https://www.cencora.com/ |
| Industria: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Subsector: |
Pharmaceuticals |
| Fin del año financiero: |
30/09 |
| Acciones de libre circulación: |
55.10% |
| Fecha de OPI: |
04/04/1995 |
